TCM Small Cap Growth Fund (TCMSX - Free Report) invests a large share of its assets in companies having market capitalizations similar to those listed in the Russell 2000 Index. TCMSX seeks growth of capital over the long term.
This Small Cap Growth product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 23.8% and 5 year 10.4%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
TCMSX’s performance, as of the last filing, when compared to funds in its category was in the top 14% over the past 1 year, and in the top 2% over the past 3 years and in the top 7% over the past 5 years.
The TCM Small Cap Growth fund, as of the last filing, allocates their fund in top two major groups; Small Growth and Large Growth. Further, as of the last filing, MasTec Inc, Lumentum Holdings Inc and Dycom Industries Inc were the top holdings for TCMSX.
This Zacks Rank #2 (Buy) was incepted in October 2004 and is managed by TCM Funds. TCMSX carries an expense ratio of 0.96% and requires a minimal initial investment of $2,500.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
TCM Small Cap Growth Fund (TCMSX - Free Report) invests a large share of its assets in companies having market capitalizations similar to those listed in the Russell 2000 Index. TCMSX seeks growth of capital over the long term.
This Small Cap Growth product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 23.8% and 5 year 10.4%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
TCMSX’s performance, as of the last filing, when compared to funds in its category was in the top 14% over the past 1 year, and in the top 2% over the past 3 years and in the top 7% over the past 5 years.
The TCM Small Cap Growth fund, as of the last filing, allocates their fund in top two major groups; Small Growth and Large Growth. Further, as of the last filing, MasTec Inc, Lumentum Holdings Inc and Dycom Industries Inc were the top holdings for TCMSX.
This Zacks Rank #2 (Buy) was incepted in October 2004 and is managed by TCM Funds. TCMSX carries an expense ratio of 0.96% and requires a minimal initial investment of $2,500.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on TCMSX - FREE